CEO of InVitae Corporation of Genomic Health Inc. Randal W. Scott Sold 30,000 Shares
Genomic Health Inc. is a life science company focused on the
development and commercialization of genomic-based clinical
diagnostic tests for cancer that allow physicians and patients to
make individualized treatment decisions. Genomic Health Inc. has
a market cap of $1.09 billion; its shares were traded at around
$35.12 with a P/E ratio of 129.4 and P/S ratio of 5.3.
On July 11, 2012, CEO of InVitae Corporation of Genomic Health Inc. ( GHDX ) Randal W. Scott sold 30,000 shares at an average price of $35.39. The total transaction amount is $1,061,70.
In 2000, Randy founded Genomic Health and served as CEO until 2009 and executive chairman until 2012. He is currently director and has also taken the role of CEO of InVitae Corporation, a wholly owned subsidiary of the company, which was established in March this year.
On June 12, 2012, CEO of InVitae Corporation Randal W. Scott sold 30,000 shares of GHDX stock at the average price of $33.54. CFO Dean L. Schorno sold 4,000 shares of GHDX stock in May, March, April and February. In May, Director and 10% Owner Julian Baker bought 854,054 shares of GHDX stock.
Genomic Health reported their 2012 first quarter financial results. The company announced net income of $777,000 and total revenues of $58.5 million.
About GuruFocus: GuruFocus.com tracks the stocks picks and portfolio holdings of the world's best investors. This value investing site offers stock screeners and valuation tools. And publishes daily articles tracking the latest moves of the world's best investors. GuruFocus also provides promising stock ideas in 3 monthly newsletters sent to Premium Members .